The time is ripe for entry into psychedelics stocks.
Articles
Red Light Holland Engages Radixmotion to Develop an Innovative Virtual Reality Shopping Experience for Dutch Smart Shops and e-Commerce Platforms
Red Light Holland is adding an education-based VR tool to its e-commerce platform.
Psychedelic Drugs and Seniors Health
Seniors are now the fastest-growing demographic of cannabis consumers. This same pattern may play out as psychedelic drugs are legalized and commercialized.
Lindsey Graham Could Be Dethroned By Pro-Pot Contender Jaime Harrison
Cannabis policies could be a deciding factor for the fate of the next US senator from South Carolina.
Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute
Mydecine's recent acquisition, NeuroPharm Inc, is about to commence clinical trials using psilocybin to treat PTSD.
Why Psychedelics Microdosing Applications Have The Inside Track On Commercialization
Microdose-based psychedelic drug therapies have several advantages , ranging from R&D and drug licensing all the way through to drug commercialization and market penetration. It all adds up to greater profit potential.
PharmaDrug Inc. Proposes a Strategic Mutual Investment with Red Light Holland Corp.
PharmaDrug (CAN:BUZZ / US:LMLLF) and Red Light Holland (CAN:TRIP) have entered into a share exchange agreement.
Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc
This release confirms Mydecine's June 10th announcement of the acquisition of NeuroPharm Inc.
New Jersey Governor Says Legalizing Marijuana A ‘No-Brainer’ For Coronavirus Economic Recovery
The governor of New Jersey said on Tuesday that legalizing marijuana could simultaneously help the state recover economically from the coronavirus pandemic while also promoting racial justice.
Reconsider Firing Workers For Marijuana, Congress Tells Federal Agencies
A key House committee has released a series reports for spending bills that include a wide range of marijuana-related provisions.
Novamind Announces Closing of Oversubscribed Private Placement
NovaMind closes on a CAD$4.4 million financing, upsized from the original CAD$3.0 million placement.
Psychedelic Drugs: the $16 TRILLION Opportunity?
A 2018 report estimates that mental health issues could cost the global economy $16 trillion between now and 2030. Psychedelic drugs are needed to mitigate those costs.
Champignon Provides Corporate Update
Champignon provides an update on its current trading halt and other corporate matters.
Congress Will Legalize Marijuana in 2021 Despite Biden Opposition, Democratic Senator Says
A Democratic U.S. senator says that if his party reclaims the Senate and White House in November, lawmakers will “move very quickly” to legalize marijuana regardless of where presumptive Democratic presidential nominee Joe Biden stands on the issue.
MagicMed Industries Files First Psychedelic Derivative Patent
MagicMed files with the USPTO with respect to its "broad portfolio of novel psilocybin molecular derivatives, the Psybrary™".